Kailera Therapeutics, Inc Common Stock
Price & Volume
Stats
See moreOpen | $18.39 |
Previous Close | $18.98 |
Day Range | $18.39-$19.13 |
52W Range | $16-$28.23 |
Market Cap | $2.4B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.78 |
News
See moreYahoo Finance • last month
Kailera Therapeutics (KLRA) is One of the Best IPO Stocks with Huge Upside Potential
Yahoo Finance • last month
Obesity drug developer Kalohexis files confidentially for U.S. IPO
Yahoo Finance • last month
Eli Lilly's Market Cap Balloons Again On This IPO's Setback
Yahoo Finance • 2 months ago
Kardigan rises in Nasdaq debut after upsized $400 million IPO
About
CEO | Mr. Ronald C. Renaud Jr., M.B.A. |
Address | 180 Third Avenue, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 145 |